Anuj Patel

1.2k total citations
31 papers, 319 citations indexed

About

Anuj Patel is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anuj Patel has authored 31 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anuj Patel's work include Colorectal Cancer Treatments and Studies (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Anuj Patel is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Anuj Patel collaborates with scholars based in United States, Switzerland and India. Anuj Patel's co-authors include Weijing Sun, Nathan Bahary, Edward Chu, Daniel P. Normolle, James Ohr, James J. Lee, Krishna Patel, Victoria Barghout, Mei Sheng Duh and Harold A. Fogel and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Cancer.

In The Last Decade

Anuj Patel

26 papers receiving 317 citations

Peers

Anuj Patel
Yu Nakaji Japan
Anuj Patel
Citations per year, relative to Anuj Patel Anuj Patel (= 1×) peers Yu Nakaji

Countries citing papers authored by Anuj Patel

Since Specialization
Citations

This map shows the geographic impact of Anuj Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anuj Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anuj Patel more than expected).

Fields of papers citing papers by Anuj Patel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anuj Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anuj Patel. The network helps show where Anuj Patel may publish in the future.

Co-authorship network of co-authors of Anuj Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Anuj Patel. A scholar is included among the top collaborators of Anuj Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anuj Patel. Anuj Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Anuj, Nilay S. Sethi, & Haeseong Park. (2026). Gastric Cancer. JAMA. 335(5). 439–439.
3.
Perez, Kimberly, Matthew H. Kulke, Hui Zheng, et al.. (2025). A phase II study of ramucirumab and somatostatin analog therapy in patients with advanced neuroendocrine tumors. The Oncologist. 30(1).
4.
Patel, Anuj, Alexander P. Marston, Cameron Sadegh, et al.. (2025). Augmented Reality Navigation in Craniomaxillofacial/Head and Neck Surgery. OTO Open. 9(2). e70108–e70108. 2 indexed citations
5.
Glick, Hannah, et al.. (2024). Evaluating Effectiveness of an Online LGBTQIA+ Health Course for Medical Students. Family Medicine. 56(5). 308–312. 1 indexed citations
6.
Starnes, Joseph R., et al.. (2024). A Novel Pediatric Clinical Skills Curriculum to Prepare Medical Students for Pediatrics Clerkship. Medical Science Educator. 35(1). 343–350.
7.
Shroff, Rachna T., Katherine A. Guthrie, Aaron J. Scott, et al.. (2023). SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers.. Journal of Clinical Oncology. 41(4_suppl). 57 indexed citations
9.
Tritschler, Tobias, Anuj Patel, Noémie Kraaijpoel, et al.. (2022). Case‐fatality rate of major bleeding events in patients on dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and meta‐analysis. Research and Practice in Thrombosis and Haemostasis. 6(7). e12834–e12834. 1 indexed citations
10.
DeVito, Nicholas C., et al.. (2022). Comprehensive genomic profiling in advanced/metastatic colorectal cancer: number needed to test and budget impact of expanded first line use. Journal of Medical Economics. 25(1). 817–825. 2 indexed citations
11.
Patel, Anuj, Lauren K. Brais, Mei Sheng Duh, et al.. (2021). Trifluridine/Tipiracil and Regorafenib in Patients with Metastatic Colorectal Cancer: A Retrospective Study at a Tertiary Oncology Center. The Oncologist. 26(12). e2161–e2169. 12 indexed citations
12.
Cleary, James M., Srivatsan Raghavan, Yvonne Y. Li, et al.. (2020). Therapeutic targeting of extracellular FGFR2 activating deletions in intrahepatic cholangiocarcinoma.. Journal of Clinical Oncology. 38(4_suppl). 567–567. 1 indexed citations
13.
Gupta, Anmol, Anuj Patel, Harold A. Fogel, et al.. (2019). DEXA sensitivity analysis in patients with adult spinal deformity. The Spine Journal. 20(2). 174–180. 31 indexed citations
14.
Patel, Anuj & D. Thomas. (2019). Indirect decompression of lumbar stenosis. Seminars in Spine Surgery. 31(3). 100712–100712. 1 indexed citations
15.
Patel, Anuj, Mei Sheng Duh, Victoria Barghout, et al.. (2018). Real-world Treatment Patterns Among Patients With Colorectal Cancer Treated With Trifluridine/Tipiracil and Regorafenib. Clinical Colorectal Cancer. 17(3). e531–e539. 18 indexed citations
16.
Sun, Weijing, Anuj Patel, Daniel P. Normolle, et al.. (2018). A phase 2 trial of regorafenib as a single agent in patients with chemotherapy‐refractory, advanced, and metastatic biliary tract adenocarcinoma. Cancer. 125(6). 902–909. 108 indexed citations
17.
Patel, Anuj, et al.. (2018). Real-world adherence in patients with metastatic colorectal cancer (mCRC) treated with trifluridine/tipiracil (FTD/TPI) or regorafenib (REG).. Journal of Clinical Oncology. 36(30_suppl). 11–11. 2 indexed citations
18.
Sun, Weijing, Daniel P. Normolle, Nathan Bahary, et al.. (2017). A phase 2 trial of regorafenib as a single agent in patients with chemotherapy refractory advanced and metastatic biliary adenocarcinoma/cholangiocarcinoma.. Journal of Clinical Oncology. 35(15_suppl). 4081–4081. 5 indexed citations
19.
Patel, Anuj & Weijing Sun. (2014). Molecular Targeted Therapy in Hepatocellular Carcinoma: From Biology to Clinical Practice and Future. Current Treatment Options in Oncology. 15(3). 380–394. 19 indexed citations
20.
Sun, Weijing & Anuj Patel. (2013). Ziv-aflibercept in metastatic colorectal cancer. Biologics. 8. 13–13. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026